Related Experiment Videos
[Relation between benign prostatic hyperplasia and obesity and estrogen]
Takaharu Matsuda1, Hiroshi Abe, Koichi Suda
1Department of Pathology, Juntendo University School of Medicine, Bunkyo-Ku, Tokyo 113-8421.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|May 29, 2004
Summary
Obesity, measured by body mass index (BMI), correlates with larger prostate size in men with benign prostatic hyperplasia (BPH). However, estrogen receptor status did not differ significantly between BMI groups.
Area of Science:
- Urology
- Endocrinology
- Pathophysiology
Context:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- The relationship between obesity, prostate volume, and hormonal factors like estrogen in BPH is not well-established.
- Previous research has suggested potential endocrine links to BPH development.
Purpose:
- To investigate the correlation between prostate resection volume, body mass index (BMI), and estrogen receptor status in patients with BPH.
- To explore the potential role of estrogen in the pathophysiology of BPH in relation to obesity.
Summary:
- This study analyzed 50 patients undergoing suprapubic prostatectomy for BPH.
- A positive correlation was found between BMI and prostate volume (p < 0.01).
- No significant difference in estrogen receptor positivity was observed between patients with BMI < 25 and BMI > 25.
Impact:
- Findings suggest a link between obesity and increased prostate size in BPH.
- Estrogen may play a role in the development of BPH, warranting further investigation.
- Highlights the need for larger population studies to validate the association between estrogen and BPH pathophysiology.